Get the app
NSEHealthcare

Laurus Labs Limited (LAURUSLABS)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,948.10+2.24%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹2,026 cr
Revenue YoY
+29.1%
Net profit
₹368 cr
Profit YoY
+125.5%
EPS
₹6.80
EPS estimate
₹4.91
Net margin
18.1%

EPS came in at 6.80 against a street estimate of 4.91 — a beat of 38.5%.

Key statistics

Market cap
₹1.06 lakh cr
P/E
97.1
Forward P/E
0.0
P/B
20.07
Book value
₹98.17
EPS (TTM)
₹20.28
52-week high
₹1,981.80
52-week low
₹821.60
50-day MA
₹1,758.05
200-day MA
₹1,296.06
Beta
0.36

Analyst view

with an average price target of ₹1,561.38.

Shareholding

Promoters
32.03%
Institutions
33.12%

Recent filings & reports

DocumentDate
Investor presentation · Q1 FY27
LAURUS LABS LIMITED – Q1 FY2027 RESULTS SUMMARY HEADLINE NUMBERS • Revenue: ₹2,026 crore in Q1 FY27, up 29% year-on-year and 12% quarter-on-quarter
2026-07-24
Quarterly results · Q1 FY27
LAURUS LABS LIMITED – Q1 FY2027 FINANCIAL SUMMARY HEADLINE NUMBERS CONSOLIDATED (Quarter ended June 30, 2026) • Revenue from operations: ₹2,026.31 c
2026-07-24
Annual report FY2026
LAURUS LABS LIMITED – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue FY 2025-26: ₹6,813 crore, up 23% year-over-year • EBITDA: ₹1
2026-06-08
Q4 FY26 earnings call
LAURUS LABS LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Total Revenue FY26: INR 6,813 crores, growth of 23% YoY • Q4 FY26 Revenue: INR 1,812 crores
2026-05-05
Quarterly results · Q4 FY26
LAURUS LABS LIMITED – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Full Year FY2025-26 Revenue from Operations: ₹6,812.90 Cr (vs ₹5,553
2026-04-30
Investor presentation
LAURUS LABS LIMITED – FY2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Total Revenue FY26: ₹6,813 Cr, up 23% YoY (₹5,554 Cr in FY25) • Q4 FY26 Re
2026-04-30
Quarterly results2026-04-28
Q3 FY26 earnings call
LAURUS LABS LIMITED Q3 FY'26 SUMMARY HEADLINE NUMBERS • Q3 FY'26 Revenue: Rs. 1,778 crores, growth of 26% year-on-year • 9-Month FY'26 Revenue: Rs.
2026-01-28

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹1.20 / share
ex-date May 8, 2026
2026-05-08
Dividend₹0.80 / share
ex-date Oct 31, 2025
2025-10-31

Deals & corporate news

AnnouncementDate
Update on acquisition of another business or strategic combination
Laurus Labs Limited has informed the Exchange about Update on Acquisition
2025-12-23
Update on acquisition of another business or strategic combination
Laurus Labs Limited has informed the Exchange about Update on Acquisition
2025-12-23

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Laurus Labs Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.